In today’s recent session, 1.29 million shares of the NLS Pharmaceutics Ltd (NASDAQ:NLSP) have been traded, and its beta is -0.21. Most recently the company’s share price was $1.50, and it changed around $0.05 or 3.10% from the last close, which brings the market valuation of the company to $3.70M. NLSP at last check was trading at a discount to its 52-week high of $18.39, offering almost -1126.0% off that amount. The share price’s 52-week low was $1.30, which indicates that the recent value has risen by an impressive 13.33% since then. We note from NLS Pharmaceutics Ltd’s average daily trading volume that its 10-day average is 22650.0 shares, with the 3-month average coming to 2.02 million.
NLS Pharmaceutics Ltd stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended NLSP as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. NLS Pharmaceutics Ltd is expected to report earnings per share of 0 for the current quarter.
NLS Pharmaceutics Ltd (NASDAQ:NLSP) trade information
Instantly NLSP has been showing a green trend so far today with a performance of 3.10% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.5999 on recent trading dayincreased the stock’s daily price by 6.24%. The company’s shares are currently down -29.15% year-to-date, but still up 9.93% over the last five days. On the other hand, NLS Pharmaceutics Ltd (NASDAQ:NLSP) is -3.55% down in the 30-day period. We can see from the shorts that 33841.0 shares have been sold at a short interest cover period of 0.97 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 7.15%.
NLSP Dividends
NLS Pharmaceutics Ltd’s next quarterly earnings report is expected to be released in May.
NLS Pharmaceutics Ltd (NASDAQ:NLSP)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 33.50% of NLS Pharmaceutics Ltd shares, and 17.37% of them are in the hands of institutional investors. The stock currently has a share float of 26.13%. NLS Pharmaceutics Ltd stock is held by 5.0 institutions, with BVF INC/IL being the largest institutional investor. By 2024-06-30, it held 15.0543% of the shares, which is about 5.75 million shares worth $1.25 million.
ARMISTICE CAPITAL, LLC, with 6.0535% or 2.31 million shares worth $0.5 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
The former held 358.0 shares worth $522.0, making up 0.01% of all outstanding shares.
